When hospice reverts to the lowest common denominator and leaders obsess about metrics, it's time to speak. Self-inflated leaders assume clinicians give until their backs break, given no raises for years. A clinical ladder is a rainbow’s pot of gold. Others have a sorrier job and must be motivated by money. Abysmal leaders dangle extrinsic rewards for admission, hiring and EDBITA targets. “Sign on” bonuses entice people into a poor work environment. Employees’ voice equals their raise, zero.
Saturday, May 5, 2018
Loyal Employee Stockholders Shafted
Strange Tony,
Kindred gave Gentiva shareholders a combination of cash and KND stock, which was valued at $18.46 on 1-30-15. Just over three years later Kindred executives crafted a deal selling the company for $9 per share.
Gentiva had an employee stock purchase plan. Any loyal employees who held onto their new Kindred stock took it on the chin as management turned their $5 in KND stock into $2.44.
That level of distress is attractive to financial rapscallions, who plan to make big money fluffing up Kindred for the put/call flip to Humana.
Anonymous (in unbalanced Kindred)
Subscribe to:
Post Comments (Atom)
Indeedy. Most that were forced to pay taxes involuntary on the cash probably held onto the stock as it briefly went up only to plummet before being sold out. Like suicide, a permanent solution to a temporary problem. Many Gentiva folks in the ESPP bought stock north of $19. What clowns in Louisville worried about building new buildings and fighting over driveways. Great clinicians, et al sadly were burned believing in their Company.
ReplyDeleteWhen Ben Breier took over as CEO for Paul Diaz Kindred's stock closed at $21.53. Breier's leadership resulted in a $12.53 haircut. That's a 58% decline in share price.
ReplyDeletePay for deformance resulted in a multi-million dollar payday for Breier.